These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adipocyte-rich Bakker A; Slack JC; Caragea M; Kurek KC; Bründler MA Pediatr Dev Pathol; 2021; 24(1):62-67. PubMed ID: 33104413 [TBL] [Abstract][Full Text] [Related]
3. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases. Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling. Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242 [TBL] [Abstract][Full Text] [Related]
5. [Gardner fibroma: case report and discussion of a new soft tissue tumor entity]. Lanckohr C; Debiec-Rychter M; Müller O; Homann HH; Lehnhardt M; Herter P; Kuhnen C Pathologe; 2010 Mar; 31(2):97-105. PubMed ID: 20063100 [TBL] [Abstract][Full Text] [Related]
6. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Coffin CM; Hornick JL; Zhou H; Fletcher CD Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483 [TBL] [Abstract][Full Text] [Related]
7. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Wehrli BM; Weiss SW; Yandow S; Coffin CM Am J Surg Pathol; 2001 May; 25(5):645-51. PubMed ID: 11342777 [TBL] [Abstract][Full Text] [Related]
8. Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence. Cates JM; Stricker TP; Sturgeon D; Coffin CM Cancer Lett; 2014 Oct; 353(2):176-81. PubMed ID: 25064609 [TBL] [Abstract][Full Text] [Related]
9. Identification of previously unrecognized FAP in children with Gardner fibroma. Vieira J; Pinto C; Afonso M; do Bom Sucesso M; Lopes P; Pinheiro M; Veiga I; Henrique R; Teixeira MR Eur J Hum Genet; 2015 May; 23(5):715-8. PubMed ID: 25074465 [TBL] [Abstract][Full Text] [Related]
10. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case. Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714 [TBL] [Abstract][Full Text] [Related]
11. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601 [TBL] [Abstract][Full Text] [Related]
12. β-Catenin mutation status and outcomes in sporadic desmoid tumors. Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186 [TBL] [Abstract][Full Text] [Related]
13. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794 [TBL] [Abstract][Full Text] [Related]
15. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors. Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455 [TBL] [Abstract][Full Text] [Related]
16. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443 [TBL] [Abstract][Full Text] [Related]
17. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations. Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042 [TBL] [Abstract][Full Text] [Related]
18. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours. Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464 [TBL] [Abstract][Full Text] [Related]
19. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor. Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222 [TBL] [Abstract][Full Text] [Related]
20. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]